2cureX AB (publ) (FRA:2QE)
Germany · Delayed Price · Currency is EUR 0.1585
-0.0380 (-19.34%)
Last updated: Jan 20, 2026, 8:04 AM CET
2cureX AB Company Description
2cureX AB (publ) operates as a medical technology company in Europe.
The company’s principal product is IndiTreat, an IVD test for the treatment of cancer by establishing 3D copies of the patient’s tumor and directly testing them against therapies.
2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
2cureX AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 14 |
| CEO | Nathaniel Hutley |
Contact Details
Address: Fruebjergvej 3 Copenhagen, 2100 Denmark | |
| Phone | 45 22 11 53 99 |
| Website | 2curex.com |
Stock Details
| Ticker Symbol | 2QE |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Nathaniel Hutley | Chief Executive Officer |
| Kenneth Johansen | Chief Financial Officer |